Showing papers by "Achille P. Caputi published in 2020"

TL;DR: The pathway that, starting from the deep understanding of ankyrins, led to the development of a new class of recombinant-binding proteins, the DARPins, which are envisaged as alternatives to mAbs and related biologics, with the potential to overcome certain shortcomings of mAbs.